Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Donald West

Plastic Surgery Marietta, GA Medical Doctor

NPI 1013972959 CMS profile 227982

823 Campbell Hill St Nw, Marietta, GA 30060

Open in the dashboard

General payments

$6,648

227 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Donald West of Marietta, GA is reported in the CMS Open Payments database as having received $6,648 across 227 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 77th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $404 18
2024 General $689 33
2023 General $618 36
2022 General $733 40
2021 General $2,569 50
2020 General $429 18
2019 General $1,206 32

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Donald West
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Donald West were reported at $404. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Donald West Plastic Surgery median Middle half National median
2019 $1,206 $371 $122–$1,483 $163
2020 $429 $158 $52–$438 $114
2021 $2,569 $249 $87–$752 $132
2022 $733 $274 $102–$793 $149
2023 $618 $299 $113–$891 $160
2024 $689 $361 $124–$1,062 $164
2025 $404 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Allergan Inc. $3,910 81 payments
  2. Mentor Worldwide LLC $1,283 72 payments
  3. AbbVie, Inc. $885 46 payments
  4. Musculoskeletal Transplant Foundation Inc. $291 17 payments
  5. Galderma Laboratories, L.P. $158 6 payments
  6. Revance Therapeutics, Inc. $79 3 payments
  7. Sientra, Inc. $24 1 payment
  8. Solventum Corporation $18 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,691 224 payments
  2. Travel and Lodging $1,958 3 payments
Products named General payments · program years 2019–2025
  1. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastics $4,381 43 payments
  2. REVOLVE $1,925 7 payments
  3. NATRELLE $1,008 23 payments
  4. BOTOX $765 41 payments
  5. MENTOR MemoryGel Resterilizable Gel Sizer $656 51 payments
  6. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastic Surgery $386 16 payments
  7. ARTOURA Breast Tissue Expander $288 6 payments
  8. MemoryGel Breast Implants $161 12 payments
  9. MENTOR MemoryGel Breast Implant $105 1 payment
  10. BOTOX COSMETIC $89 6 payments
  11. Other $234 9 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

39

Median for Plastic Surgery: 39

Drug cost

$142

Median for Plastic Surgery: $219

Branded share of claims

100%

Median for Plastic Surgery: 30%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 21 $115
Ondansetron Odt Ondansetron Brand 18 $27

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 700 Part D prescribers listed as Plastic Surgery; they describe a distribution and say nothing about conduct.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
BOTOX
  • AbbVie, Inc. $182
$182 — —
DAXXIFY
  • REVANCE THERAPEUTICS, INC. $43
$43 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

227 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record